2018 ESPCG国际共识:益生菌在下消化道症状管理中的应用(更新版)

2018-02-20 欧洲基础治疗胃肠病学会 Aliment Pharmacol Ther. 2018 Feb 20.

2018年2月,欧洲基础治疗胃肠病学会(ESPCG)跟新发布了益生菌在下消化道症状管理中的应用共识,本文是对2013年版共识的更新,主要内容包括IBS症状评估,益生菌对腹痛、腹胀、胃肠胀气、便秘、排便习惯、腹泻、健康相关的生活质量的作用以及益生菌的副作用等。

中文标题:

2018 ESPCG国际共识:益生菌在下消化道症状管理中的应用(更新版)

英文标题:

Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.

发布日期:

2018-02-20

简要介绍:

2018年2月,欧洲基础治疗胃肠病学会(ESPCG)跟新发布了益生菌在下消化道症状管理中的应用共识,本文是对2013年版共识的更新,主要内容包括IBS症状评估,益生菌对腹痛、腹胀、胃肠胀气、便秘、排便习惯、腹泻、健康相关的生活质量的作用以及益生菌的副作用等。

 

拓展指南:消化道相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ESPCG国际共识:益生菌在下消化道症状管理中的应用(更新版))] GetToolGuiderByIdResponse(projectId=1, id=b333c1c0015601ca, title=2018 ESPCG国际共识:益生菌在下消化道症状管理中的应用(更新版), enTitle=Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus., guiderFrom=Aliment Pharmacol Ther. 2018 Feb 20., authorId=null, author=, summary=2018年2月,欧洲基础治疗胃肠病学会(ESPCG)跟新发布了益生菌在下消化道症状管理中的应用共识,本文是对2013年版共识的更新,主要内容包括IBS症状评估,益生菌对腹痛、腹胀、胃肠胀气、便秘、排便习惯、腹泻、健康相关的生活质量的作用以及益生菌的副作用等。 , cover=, journalId=null, articlesId=null, associationId=801, associationName=欧洲基础治疗胃肠病学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Feb 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年2月,欧洲基础治疗胃肠病学会(ESPCG)跟新发布了益生菌在下消化道症状管理中的应用共识,本文是对2013年版共识的更新,主要内容包括IBS症状评估,益生菌对腹痛、腹胀、胃肠胀气、便秘、排便习惯、腹泻、健康相关的生活质量的作用以及益生菌的副作用等。 </P> <P> </P>拓展指南:<strong>与<font color=red>消化道</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6f44e1c0015165cf" title="消化道恶性肿瘤合理用药指南" target=_blank>消化道恶性肿瘤合理用药指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=067381c001ae94ac" title="非甾体消炎药相关消化道溃疡与溃疡并发症的预防与治疗规范建议" target=_blank>非甾体消炎药相关消化道溃疡与溃疡并发症的预防与治疗规范建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=be29b1c001ae38c8" title="2017 ESGE指南:下消化道内镜检查" target=_blank>2017 ESGE指南:下消化道内镜检查</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=893f11c001a09493" title="消化道肿瘤多学科综合治疗协作组诊疗模式专家共识" target=_blank>消化道肿瘤多学科综合治疗协作组诊疗模式专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1c5961c00130360f" title="2016 NICE指南:16岁及以上人群上呼吸消化道肿瘤的评估和管理(NG.36)" target=_blank>2016 NICE指南:16岁及以上人群上呼吸消化道肿瘤的评估和管理(NG.36)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%B6%88%E5%8C%96%E9%81%93" target=_blank>有关消化道更多指南</a></ul>, tagList=[TagDto(tagId=3718, tagName=益生菌), TagDto(tagId=70635, tagName=下消化道症状)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4907, appHits=355, showAppHits=7, pcHits=3581, showPcHits=1532, likes=125, shares=11, comments=4, approvalStatus=1, publishedTime=Tue Feb 27 11:25:45 CST 2018, publishedTimeString=2018-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 27 11:25:45 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:32:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESPCG国际共识:益生菌在下消化道症状管理中的应用(更新版))])
2018 ESPCG国际共识:益生菌在下消化道症状管理中的应用(更新版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=887859, encodeId=b50988e85928, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ad5221012, createdName=1477d400m02(暂无昵称), createdTime=Thu Sep 24 09:26:38 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310677, encodeId=eaf93106e7e8, content=厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/d9d14db78de202d73276f47d8d8e2596.jpg, createdBy=3b682249905, createdName=盖伦, createdTime=Mon Apr 30 09:15:03 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291855, encodeId=fdc729185560, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 01 03:38:28 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291528, encodeId=41b329152821, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Feb 28 03:54:11 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2020-09-24 1477d400m02(暂无昵称)

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=887859, encodeId=b50988e85928, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ad5221012, createdName=1477d400m02(暂无昵称), createdTime=Thu Sep 24 09:26:38 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310677, encodeId=eaf93106e7e8, content=厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/d9d14db78de202d73276f47d8d8e2596.jpg, createdBy=3b682249905, createdName=盖伦, createdTime=Mon Apr 30 09:15:03 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291855, encodeId=fdc729185560, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 01 03:38:28 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291528, encodeId=41b329152821, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Feb 28 03:54:11 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-04-30 盖伦

    厉害了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=887859, encodeId=b50988e85928, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ad5221012, createdName=1477d400m02(暂无昵称), createdTime=Thu Sep 24 09:26:38 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310677, encodeId=eaf93106e7e8, content=厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/d9d14db78de202d73276f47d8d8e2596.jpg, createdBy=3b682249905, createdName=盖伦, createdTime=Mon Apr 30 09:15:03 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291855, encodeId=fdc729185560, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 01 03:38:28 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291528, encodeId=41b329152821, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Feb 28 03:54:11 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-03-01 秀红

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=887859, encodeId=b50988e85928, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ad5221012, createdName=1477d400m02(暂无昵称), createdTime=Thu Sep 24 09:26:38 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310677, encodeId=eaf93106e7e8, content=厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/d9d14db78de202d73276f47d8d8e2596.jpg, createdBy=3b682249905, createdName=盖伦, createdTime=Mon Apr 30 09:15:03 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291855, encodeId=fdc729185560, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 01 03:38:28 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291528, encodeId=41b329152821, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Feb 28 03:54:11 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-02-28 121832a9m88暂无昵称

    学习了

    0